Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes - Carlquist, JF; Knight, S; Horne, BD (Thromb Haemost, 2013)
et al.